Last June, Star Tribune reporters uncovered yet another medical research scandal in Minneapolis. This time it was Hennepin Healthcare. At the direction of researchers in the Department of Emergency Medicine, paramedics were testing a risky anesthetic called ketamine on agitated patients without their consent. As many as 47 percent of the patients forcibly injected with ketamine had breathing problems so severe they wound up on a ventilator.
Hennepin Healthcare leaders insisted they had done nothing wrong. "We are following all the rules and regulations that govern research at all the other U.S. academic medical centers," Chief Medical Officer William Heegaard told the Hennepin County Board on June 26.
The U.S. Food and Drug Administration disagrees. According to an inspection report obtained by Public Citizen, Hennepin Healthcare has known since August that the FDA found serious ethical and regulatory violations. It is now clear there has been a systemic breakdown in research oversight at Hennepin Healthcare, yet its leaders have repeatedly refused to release information about the study or how it managed to get ethical approval by its Institutional Review Board.
Why does unethical research take place so often in Minnesota? These forced ketamine studies and the suicide of Dan Markingson in a University of Minnesota drug study are only the most visible cases in a string of research scandals dating back to the 1990s.
In the University of Minnesota's Department of Surgery, the ALG transplant drug scandal ended with a five-year NIH probation, a $32 million federal settlement and the departure of 86 faculty members in the Medical School.
Scandals in the Department of Psychiatry resulted in a federal prison sentence for the head of child psychiatry and the FDA disqualification of the director of the chemical-dependency unit.
In 2007, the New York Times reported on the quiet rehabilitation of a Minneapolis psychiatrist responsible for the deaths or injuries of 46 patients, 17 of them in research studies.
Yet to many people, these scandals barely seem to register. Often they are forgotten as soon as it they are reported. At most, the issues simmer quietly for years as attorneys and regulators fight over a face-saving settlement. Almost never are any real lessons learned.